Ellevest, Inc. Neogenomics Inc Transaction History

Ellevest, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$9.09 - $19.45 $1,336 - $2,859	147 Added 90.18%	310 $5,000
Q4 2022 Feb 03, 2023	SELL	$6.45 - $12.07 $470 - $881	-73 Reduced 30.93%	163 $1,000
Q3 2022 Nov 02, 2022	BUY	$7.86 - $12.91 $1,854 - $3,046	236 New	236 $2,000
Q2 2022 Jul 18, 2022	SELL	$7.06 - $13.97 $42 - $83	-6 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$12.15 - $35.28 $72 - $211	6 New	6 $0
Q2 2021 Jul 13, 2021	SELL	$36.62 - $51.69 $1,428 - $2,015	-39 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$41.56 - $59.88 $540 - $778	13 Added 50.0%	39 $2,000
Q4 2020 Feb 04, 2021	BUY	$36.08 - $56.47 $938 - $1,468	26 New	26 $1,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.07B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.